...
首页> 外文期刊>Gene therapy >Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5′-LTR promoter
【24h】

Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5′-LTR promoter

机译:利用针对HIV-1 5'-LTR启动子的设计锌指转录因子特异性激活潜在HIV-1

获取原文
获取原文并翻译 | 示例

摘要

HIV-1 latency remains the primary obstacle to the eradication of this virus. The current latency-reversing agents cannot effectively and specifically eliminate latent HIV-1 reservoirs. Therefore, better approaches are urgently needed. In this study, we describe a novel strategy to reactivate latent HIV-1 using zinc-finger transcription factors composed of designer zinc-finger proteins and the transcriptional activation domain VP64. For the first time, we demonstrate that ZF-VP64 with HIV-1 long terminal repeat (LTR) promoter-specific affinity could significantly reactivate HIV-1 expression from latently infected cells without altering cell proliferation or cell cycle progression. We also provide evidence that the reactivation of HIV-1 by ZF-VP64 occurs through specific binding to the 5′-LTR promoter. Our results demonstrate the potential of this novel approach for anti-HIV-1 latency therapy.
机译:HIV-1潜伏期仍然是根除该病毒的主要障碍。当前的潜伏期逆转剂不能有效地和特异性地消除潜在的HIV-1贮藏库。因此,迫切需要更好的方法。在这项研究中,我们描述了一种新的策略来使用由设计者锌指蛋白和转录激活域VP64组成的锌指转录因子来激活潜在HIV-1。首次,我们证明具有HIV-1长末端重复序列(LTR)启动子特异性亲和力的ZF-VP64可以显着激活潜伏感染细胞中的HIV-1表达,而不会改变细胞增殖或细胞周期进程。我们还提供证据表明ZF-VP64对HIV-1的激活是通过与5'-LTR启动子的特异性结合而发生的。我们的结果证明了这种抗HIV-1潜伏期治疗新方法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号